$NHHS
NorthStar Healthcare Income, Inc.

2022 Q4 Form 10-Q Financial Statement

#000150370722000035 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $47.74M
YoY Change -25.89%
Cost Of Revenue $35.13M
YoY Change -23.26%
Gross Profit $12.61M
YoY Change -32.34%
Gross Profit Margin 26.4%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.642M
YoY Change -30.27%
% of Gross Profit 76.49%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $11.01M
YoY Change -30.2%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$32.37M
YoY Change 64.84%
Income Tax $15.00K
% Of Pretax Income
Net Earnings -$29.51M
YoY Change 151.11%
Net Earnings / Revenue -61.82%
Basic Earnings Per Share -$0.15
Diluted Earnings Per Share -$0.15
COMMON SHARES
Basic Shares Outstanding 195.3M shares 194.7M shares
Diluted Shares Outstanding 194.7M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $103.9M $95.15M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $2.253M $2.337M
YoY Change -13.01%
Long-Term Investments $176.5M $205.2M
YoY Change -16.87% -7.12%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.238B $1.259B
YoY Change -12.39% -30.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $936.8M $942.2M
YoY Change -3.03% -34.03%
SHAREHOLDERS EQUITY
Retained Earnings -$1.429B -$1.410B
YoY Change 11.83% 5.9%
Common Stock $1.732B $1.730B
YoY Change 0.52% 0.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $299.0M $314.9M
YoY Change
Total Liabilities & Shareholders Equity $1.238B $1.259B
YoY Change -12.39% -30.74%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$29.51M
YoY Change 151.11%
Depreciation, Depletion And Amortization $9.642M
YoY Change -30.27%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001503707
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#RealEstateInvestmentPropertyNet
CY2022Q3 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55190
dei Entity Registrant Name
EntityRegistrantName
NORTHSTAR HEALTHCARE INCOME, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3663988
dei Entity Address Address Line1
EntityAddressAddressLine1
16 East 34th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
18th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10016
dei City Area Code
CityAreaCode
929
dei Local Phone Number
LocalPhoneNumber
777-3135
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
195287174 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95145000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200473000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
12537000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
10465000 usd
CY2022Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
932730000 usd
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
972599000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
205207000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
212309000 usd
CY2022Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
3454000 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3666000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2337000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2590000 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
7829000 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
10771000 usd
CY2022Q3 us-gaap Assets
Assets
1259239000 usd
CY2021Q4 us-gaap Assets
Assets
1412873000 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
915964000 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
929811000 usd
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3347000 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
7338000 usd
CY2022Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1427000 usd
CY2021Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1171000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
19052000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
24671000 usd
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
2392000 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
3064000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
942182000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8544000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9642000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13828000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
18500000 usd
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4600000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
31502000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
85193000 usd
us-gaap Costs And Expenses
CostsAndExpenses
212431000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
966055000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195078539 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195078539 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
193120940 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
193120940 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1951000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1930000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1728383000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1720719000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1410309000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1277688000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5088000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-486000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
314937000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
444475000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
2120000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
2343000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
317057000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
446818000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1259239000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1412873000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11274000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
27370000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32987000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
83906000 usd
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
36165000 usd
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
37006000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
103001000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
101669000 usd
CY2022Q3 us-gaap Other Operating Income
OtherOperatingIncome
300000 usd
CY2021Q3 us-gaap Other Operating Income
OtherOperatingIncome
38000 usd
us-gaap Other Operating Income
OtherOperatingIncome
457000 usd
us-gaap Other Operating Income
OtherOperatingIncome
80000 usd
CY2022Q3 us-gaap Revenues
Revenues
47739000 usd
CY2021Q3 us-gaap Revenues
Revenues
64414000 usd
us-gaap Revenues
Revenues
136445000 usd
us-gaap Revenues
Revenues
185655000 usd
CY2022Q3 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
0 usd
CY2021Q3 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
1067000 usd
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
0 usd
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
4667000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35134000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45784000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
101258000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136503000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
11014000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29105000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
15780000 usd
us-gaap Interest Expense
InterestExpense
31877000 usd
us-gaap Interest Expense
InterestExpense
47767000 usd
CY2022Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
857000 usd
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
857000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 usd
CY2022Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2428000 usd
CY2021Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
7532000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
8307000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2859000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2432000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10300000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9642000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13828000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
18500000 usd
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4600000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
31502000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5386000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
80434000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
85193000 usd
us-gaap Costs And Expenses
CostsAndExpenses
212431000 usd
us-gaap Costs And Expenses
CostsAndExpenses
251333000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000 usd
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
325000 usd
CY2021Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
75000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
660000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-29513000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 usd
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
325000 usd
CY2021Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
75000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
660000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19637000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-75249000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-46640000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2872000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7943000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39427000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-32370000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19637000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-75249000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-46640000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2872000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7943000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39427000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-29513000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 usd
us-gaap Profit Loss
ProfitLoss
-35867000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-73000 usd
us-gaap Profit Loss
ProfitLoss
-35867000 usd
us-gaap Profit Loss
ProfitLoss
-28906000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-73000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-298000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
73000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29440000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-29440000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11653000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11653000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35569000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-35569000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28979000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
73000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29440000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-29440000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11653000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35569000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-35569000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28979000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28979000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
194670948 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
194670948 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
194670948 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
191937161 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191937161 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
194032819 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
194032819 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191285186 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
191285186 shares
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
49872 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
66840 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
194032819 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
194032819 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
191285186 shares
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
66840 shares
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-29513000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 usd
us-gaap Profit Loss
ProfitLoss
-35867000 usd
us-gaap Profit Loss
ProfitLoss
-28906000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1664000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-671000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4602000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1664000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-671000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4602000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-29513000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 usd
us-gaap Profit Loss
ProfitLoss
-35867000 usd
us-gaap Profit Loss
ProfitLoss
-28906000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1664000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-671000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4602000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1253000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1664000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-671000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4602000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1253000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-31177000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-40469000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-30159000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-73000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1253000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-31177000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12424000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-40469000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-30159000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-73000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-100000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-298000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
73000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31104000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12324000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40171000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30232000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-474000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-10155000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-100000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-298000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
73000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31104000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30232000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
412062000 usd
CY2021Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46000 usd
CY2021Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
240000 usd
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
350000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-474000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-10155000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403869000 usd
CY2021Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73000 usd
CY2021Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
146000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403869000 usd
CY2021Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73000 usd
CY2021Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
146000 usd
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
399449000 usd
CY2021Q3 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2769000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23000 usd
CY2021Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
259000 usd
CY2021Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
45000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-671000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390031000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
446818000 usd
CY2022Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2729000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15000 usd
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-108000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
399449000 usd
CY2021Q3 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2769000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23000 usd
CY2021Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
259000 usd
CY2021Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
45000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-671000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 usd
CY2022Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2729000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-568000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-12981000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
436024000 usd
CY2022Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2515000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
64000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
53000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-568000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000 usd
CY2022Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
113000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
61000 usd
CY2022Q2 us-gaap Dividends
Dividends
97052000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2370000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6627000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
345809000 usd
CY2022Q3 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2413000 usd
CY2022Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
86000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
317057000 usd
us-gaap Profit Loss
ProfitLoss
-35867000 usd
us-gaap Profit Loss
ProfitLoss
-28906000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39427000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000 usd
CY2022Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
113000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
61000 usd
CY2022Q3 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2413000 usd
CY2022Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
86000 usd
CY2022Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
74000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1664000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-29513000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
317057000 usd
us-gaap Profit Loss
ProfitLoss
-35867000 usd
us-gaap Profit Loss
ProfitLoss
-28906000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39427000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5386000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2428000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2369000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29105000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
31502000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5386000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2428000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2369000 usd
us-gaap Straight Line Rent
StraightLineRent
0 usd
us-gaap Straight Line Rent
StraightLineRent
-7432000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
697000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
475000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1354000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
150000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
142000 usd
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
0 usd
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
194000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
660000 usd
us-gaap Straight Line Rent
StraightLineRent
0 usd
us-gaap Straight Line Rent
StraightLineRent
-7432000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
142000 usd
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
0 usd
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
194000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
326000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7532000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7769000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
114000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1191000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3583000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7560000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-3868000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-5421000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
326000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7532000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7769000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
114000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1191000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3583000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7560000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-3868000 usd
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
256000 usd
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
1758000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8727000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8866000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-298000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4355000 usd
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
17924000 usd
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
256000 usd
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
1758000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-298000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
306000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13604000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4355000 usd
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
17924000 usd
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
17344000 usd
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
0 usd
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
28078000 usd
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
0 usd
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
74376000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
400000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
42173000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
6971000 usd
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
0 usd
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
28078000 usd
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
400000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
42173000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
6971000 usd
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
0 usd
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
686000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
16514000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
35000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
408000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
97018000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
263000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
645000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
188000 usd
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
686000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24249000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
92367000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
26000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
16514000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
61121000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
35000000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
36000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
708000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
408000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
446000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
263000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93570000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107682000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
428000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-113901000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71058000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-103256000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16954000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210938000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93570000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107682000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110524000 usd
us-gaap Interest Paid Net
InterestPaidNet
28625000 usd
us-gaap Interest Paid Net
InterestPaidNet
50277000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
41000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
45000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2561000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1391000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110524000 usd
us-gaap Interest Paid Net
InterestPaidNet
28625000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
45000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2561000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1391000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
144000 usd
nshi Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale
NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale
488241000 usd
us-gaap Nature Of Operations
NatureOfOperations
Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), manages a diversified portfolio of investments in healthcare real estate, owned directly or through joint ventures, with a focus on the seniors housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living facilities (“ILF”) and continuing care retirement communities (“CCRC”), which have ILF, ALF, SNF, and MCF available on one campus. The Company is also invested in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but through a joint venture it also has international investments in the United Kingdom. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”). NorthStar Healthcare Income Advisor, LLC invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of September 30, 2022 and December 31, 2021. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of September 30, 2022, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since inception through October 21, 2022, the Company was externally managed by CNI NSHC Advisors, LLC or its predecessor (the “Advisor”), an affiliate of NRF Holdco, LLC (the “Sponsor”). The Advisor was responsible for managing the Company’s operations, subject to the supervision of the Company’s board of directors, pursuant to an advisory agreement. On October 21, 2022, the Company completed the internalization of the Company’s management function (the “Internalization”). In connection with the Internalization, the Company agreed with the Advisor to terminate the advisory agreement and arranged for the Advisor to continue to provide certain services for a transition period. Going forward, the Company will be self-managed under the leadership of Kendall Young, who was appointed by the board of directors as Chief Executive Officer and President concurrent with the Internalization. Refer to Note 13, “Subsequent Events” for further discussion.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through September 30, 2022, the Company raised $2.0 billion in total gross proceeds from the sale of shares of common stock in its continuous, public offerings (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's healthcare real estate business and investments have been challenged by suboptimal occupancy levels, lower labor force participation rates, which has driven increased labor costs, and inflationary pressures on other operating expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These lasting effects from the response to the coronavirus 2019 (“COVID-19”) pandemic will continue to impact Company’s operational and financial performance. An extended recovery period increases the risk of a prolonged negative impact on the Company’s financial condition and results of operations. While the Company has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue, and the effects of COVID-19 may also lead to heightened risk of litigation, with an ensuing increase in litigation and related costs.</span></div>At this time, the progression of the global economic recovery remains difficult for the Company to assess and estimate the future impact on the Company's results of operations. Accordingly, any estimates as reflected or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of the economic recovery and reassess its effects on the Company’s results of operations and recoverability of value across its assets as conditions change.
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95145000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200473000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
144000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
100000 usd
nshi Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale
NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale
0 usd
nshi Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale
NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale
488241000 usd
us-gaap Nature Of Operations
NatureOfOperations
Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), manages a diversified portfolio of investments in healthcare real estate, owned directly or through joint ventures, with a focus on the seniors housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living facilities (“ILF”) and continuing care retirement communities (“CCRC”), which have ILF, ALF, SNF, and MCF available on one campus. The Company is also invested in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but through a joint venture it also has international investments in the United Kingdom. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”). NorthStar Healthcare Income Advisor, LLC invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of September 30, 2022 and December 31, 2021. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of September 30, 2022, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since inception through October 21, 2022, the Company was externally managed by CNI NSHC Advisors, LLC or its predecessor (the “Advisor”), an affiliate of NRF Holdco, LLC (the “Sponsor”). The Advisor was responsible for managing the Company’s operations, subject to the supervision of the Company’s board of directors, pursuant to an advisory agreement. On October 21, 2022, the Company completed the internalization of the Company’s management function (the “Internalization”). In connection with the Internalization, the Company agreed with the Advisor to terminate the advisory agreement and arranged for the Advisor to continue to provide certain services for a transition period. Going forward, the Company will be self-managed under the leadership of Kendall Young, who was appointed by the board of directors as Chief Executive Officer and President concurrent with the Internalization. Refer to Note 13, “Subsequent Events” for further discussion.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through September 30, 2022, the Company raised $2.0 billion in total gross proceeds from the sale of shares of common stock in its continuous, public offerings (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's healthcare real estate business and investments have been challenged by suboptimal occupancy levels, lower labor force participation rates, which has driven increased labor costs, and inflationary pressures on other operating expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These lasting effects from the response to the coronavirus 2019 (“COVID-19”) pandemic will continue to impact Company’s operational and financial performance. An extended recovery period increases the risk of a prolonged negative impact on the Company’s financial condition and results of operations. While the Company has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue, and the effects of COVID-19 may also lead to heightened risk of litigation, with an ensuing increase in litigation and related costs.</span></div>At this time, the progression of the global economic recovery remains difficult for the Company to assess and estimate the future impact on the Company's results of operations. Accordingly, any estimates as reflected or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of the economic recovery and reassess its effects on the Company’s results of operations and recoverability of value across its assets as conditions change.
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
205200000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
205200000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of COVID-19 pandemic, inflation, rising interest rates, risk of recession and other economic conditions as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q. Such estimates may change and the impact of which could be material.</span></div>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95145000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200473000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
12537000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
10465000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210938000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
117559000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
12537000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
10465000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107682000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210938000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2500000 usd
nshi Finance Lease Payments
FinanceLeasePayments
500000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2500000 usd
nshi Finance Lease Payments
FinanceLeasePayments
400000 usd
nshi Finance Lease Payments
FinanceLeasePayments
500000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
24000 usd
CY2022Q3 nshi Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
28000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
303000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
69000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
93000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
60000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
29000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
24000 usd
CY2022Q3 nshi Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
28000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
303000 usd
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
29000 usd
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
274000 usd
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.072
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
29000 usd
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
274000 usd
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.072
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2022Q3 nshi Number Of Triple Net Lease Portfolios
NumberOfTripleNetLeasePortfolios
4 portfolio
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
117812000 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
9200000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5400000 usd
CY2022Q3 nshi Number Of Triple Net Lease Portfolios
NumberOfTripleNetLeasePortfolios
4 portfolio
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
117812000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
117559000 usd
CY2022Q3 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
100000 usd
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
300000 usd
CY2021Q3 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
300000 usd
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
1300000 usd
CY2022Q3 nshi Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year
DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear
84000 usd
CY2022Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne
337000 usd
CY2022Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
337000 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
10100000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2337000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2590000 usd
CY2022Q3 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
100000 usd
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
300000 usd
CY2021Q3 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
300000 usd
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
1300000 usd
CY2022Q3 nshi Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year
DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear
84000 usd
CY2022Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne
337000 usd
CY2022Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
337000 usd
CY2022Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree
337000 usd
CY2022Q3 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 day
CY2022Q3 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 day
CY2022Q3 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
2100000 usd
CY2021Q3 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
3500000 usd
nshi Impairment Charges For Property Damages
ImpairmentChargesForPropertyDamages
600000 usd
CY2022Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree
337000 usd
CY2022Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour
337000 usd
CY2022Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
905000 usd
CY2022Q3 nshi Deferred Costsand Finite Lived Intangible Assets Net
DeferredCostsandFiniteLivedIntangibleAssetsNet
2337000 usd
CY2022Q3 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 day
CY2022Q3 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 day
CY2022Q3 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
2100000 usd
CY2021Q3 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
3500000 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
9200000 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
10100000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
31500000 usd
nshi Impairment Charges For Property Damages
ImpairmentChargesForPropertyDamages
600000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5400000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q3 nshi Acquisition Feeand Expense Cap
AcquisitionFeeandExpenseCap
0.060
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14500000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
31500000 usd
CY2022Q3 nshi Acquisition Feeand Expense Cap
AcquisitionFeeandExpenseCap
0.060
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000 usd
CY2021Q4 us-gaap Land
Land
121518000 usd
CY2022Q3 us-gaap Land Improvements
LandImprovements
18453000 usd
CY2021Q4 us-gaap Land Improvements
LandImprovements
17798000 usd
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
965630000 usd
CY2022Q3 us-gaap Tenant Improvements
TenantImprovements
322000 usd
CY2022Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
12154000 usd
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
8141000 usd
CY2022Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
88910000 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
84813000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 usd
CY2022Q3 us-gaap Land
Land
121518000 usd
CY2021Q4 us-gaap Land
Land
121518000 usd
CY2022Q3 us-gaap Land Improvements
LandImprovements
18453000 usd
CY2021Q4 us-gaap Land Improvements
LandImprovements
17798000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
5400000 usd
CY2022Q3 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
945526000 usd
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
965630000 usd
CY2022Q3 us-gaap Tenant Improvements
TenantImprovements
322000 usd
CY2021Q4 us-gaap Tenant Improvements
TenantImprovements
0 usd
CY2022Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
12154000 usd
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
8141000 usd
CY2022Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
88910000 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
84813000 usd
CY2022Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1186883000 usd
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1197900000 usd
CY2022Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
254153000 usd
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
225301000 usd
CY2022Q3 us-gaap Real Estate Investments
RealEstateInvestments
932730000 usd
CY2021Q4 us-gaap Real Estate Investments
RealEstateInvestments
972599000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
13500000 usd
us-gaap Depreciation
Depreciation
43500000 usd
CY2022Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1186883000 usd
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1197900000 usd
CY2022Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
254153000 usd
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
225301000 usd
CY2022Q3 us-gaap Real Estate Investments
RealEstateInvestments
932730000 usd
CY2021Q4 us-gaap Real Estate Investments
RealEstateInvestments
972599000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
9600000 usd
us-gaap Depreciation
Depreciation
28900000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
31500000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
5400000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
205207000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
212309000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7943000 usd
CY2021Q3 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3942000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39427000 usd
nshi Impairment Charges For Property Damages
ImpairmentChargesForPropertyDamages
600000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
42173000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
212309000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2872000 usd
CY2022Q3 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4033000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7943000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6971000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4948000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20406000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
46964000 usd
CY2022Q3 nshi Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
153398000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
927050000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6971000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4948000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
31032000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20406000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
670302000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
46964000 usd
CY2022Q3 nshi Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
153398000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
927050000 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
7338000 usd
nshi Related Party Transaction Dueto Related Parties Amount Incurred
RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred
16321000 usd
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3347000 usd
nshi Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees
2000000 shares
nshi Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees
7700000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
56875 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55625 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
150042 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
174458 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
268125 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
7338000 usd
nshi Related Party Transaction Dueto Related Parties Amount Incurred
RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred
16321000 usd
nshi Related Party Transaction Dueto Related Parties Amount Paid
RelatedPartyTransactionDuetoRelatedPartiesAmountPaid
20312000 usd
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3347000 usd
nshi Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees
2000000 shares
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55625 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
174458 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
268125 usd
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
97100000 usd
CY2022Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
97000000 usd
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
223167 usd
CY2022Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
97100000 usd
CY2022Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
97000000 usd
CY2022Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
33419 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
226500000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-300000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
100000 usd
CY2022Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
33419 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
226500000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-300000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
100000 usd
nshi Impairment Charges For Property Damages
ImpairmentChargesForPropertyDamages
600000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 segment
CY2022Q3 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
47739000 usd
CY2022Q3 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35134000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 segment
CY2022Q3 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
47739000 usd
CY2022Q3 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35134000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
11014000 usd
CY2022Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2428000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2859000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9642000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
18500000 usd
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
325000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2872000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-29513000 usd
CY2021Q3 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
64414000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
11014000 usd
CY2022Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
857000 usd
CY2022Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2428000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2859000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9642000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
18500000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
325000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2872000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-29513000 usd
CY2021Q3 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
64414000 usd
CY2021Q3 us-gaap Interest Income Operating
InterestIncomeOperating
1067000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45784000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
15780000 usd
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2021Q3 us-gaap Interest Income Operating
InterestIncomeOperating
1067000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
15780000 usd
CY2021Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2432000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13828000 usd
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4600000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
75000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7943000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 usd
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
136445000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
101258000 usd
us-gaap Interest Expense
InterestExpense
31877000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29105000 usd
CY2021Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2432000 usd
CY2021Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
75000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
101258000 usd
us-gaap Interest Expense
InterestExpense
31877000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
857000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
7532000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10300000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29105000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
31502000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
660000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39427000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
us-gaap Profit Loss
ProfitLoss
-35867000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
660000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39427000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
us-gaap Profit Loss
ProfitLoss
-35867000 usd
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
185655000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
4667000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136503000 usd
us-gaap Interest Expense
InterestExpense
47767000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8544000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5386000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 usd
us-gaap Profit Loss
ProfitLoss
-28906000 usd
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
185655000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
4667000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136503000 usd
us-gaap Interest Expense
InterestExpense
47767000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
8307000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8544000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5386000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 usd
us-gaap Profit Loss
ProfitLoss
-28906000 usd
CY2022Q3 us-gaap Assets
Assets
1259239000 usd
CY2021Q4 us-gaap Assets
Assets
1412873000 usd
CY2022Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
56 property
CY2022Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
6822 unit
us-gaap Noninterest Income
NoninterestIncome
136445000 usd
CY2022Q3 us-gaap Assets
Assets
1259239000 usd
CY2021Q4 us-gaap Assets
Assets
1412873000 usd
CY2022Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
56 property
CY2022Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
6822 unit
us-gaap Noninterest Income
NoninterestIncome
136445000 usd

Files In Submission

Name View Source Status
0001503707-22-000035-index-headers.html Edgar Link pending
0001503707-22-000035-index.html Edgar Link pending
0001503707-22-000035.txt Edgar Link pending
0001503707-22-000035-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nshi-20220930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nshi-20220930.xsd Edgar Link pending
nshi-20220930_g1.jpg Edgar Link pending
nshi-20220930_g2.jpg Edgar Link pending
nshi09302022exhibit311.htm Edgar Link pending
nshi09302022exhibit312.htm Edgar Link pending
nshi09302022exhibit321.htm Edgar Link pending
nshi09302022exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
nshi-20220930_def.xml Edgar Link unprocessable
nshi-20220930_lab.xml Edgar Link unprocessable
nshi-20220930_pre.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nshi-20220930_cal.xml Edgar Link unprocessable
nshi-20220930_htm.xml Edgar Link completed